Literature DB >> 11709450

Detection of immune deposits in skin lesions of patients with Wegener's granulomatosis.

R H Brons1, M C de Jong, N K de Boer, C A Stegeman, C G Kallenberg, J W Tervaert.   

Abstract

BACKGROUND: Wegener's granulomatosis (WG) is considered a pauci-immune systemic vasculitis based on the absence of immune deposits in renal biopsies of patients with active disease. In animal models of antineutrophil cytoplasmic antibody (ANCA) associated glomerulonephritis, immune deposits along the glomerular capillary wall are present at early stages of lesion development. These deposits are degraded rapidly, resulting in "pauci-immune" lesions.
OBJECTIVE: To test the hypothesis that immune deposits can also be detected in early lesions of patients with WG, thereby initiating an inflammatory reaction that, in time, is augmented in the presence of ANCA, resulting in pauci-immune lesions later on.
METHODS: The presence of immune deposits in skin biopsies taken within 48 hours of lesion development was investigated. Direct immunofluorescence was used to examine 32 skin biopsies for the presence of immune deposits (IgG, IgA, IgM, C3c). When possible, a comparison was made between the immunofluorescence findings in renal and skin biopsies taken at the same time.
RESULTS: Four of 11 biopsies taken at initial presentation and four of 21 biopsies taken at the onset of a relapse of WG showed IgG and/or IgA containing immune deposits in the subepidermal blood vessels. All nine renal biopsies showed pauci-immune glomerulonephritis, irrespective of the presence (n=5) or absence (n=4) of immune deposits in the skin biopsy.
CONCLUSION: A substantial number of skin biopsies showed immune deposits during active disease. These results could support the hypothesis that immune complexes may trigger vasculitic lesions in WG.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11709450      PMCID: PMC1753448          DOI: 10.1136/ard.60.12.1097

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  39 in total

1.  Simultaneous IgA nephropathy and Wegener's granulomatosis--overlap or coincidence (the role of renal biopsy).

Authors:  F Vrtovsnik; G Queffeulou; H Skhiri; D Nochy; F Walker; G Hayem; F Mignon
Journal:  Nephrol Dial Transplant       Date:  1999-05       Impact factor: 5.992

Review 2.  Is Wegener's granulomatosis an autoimmune disease?

Authors:  P Hewins; J W Tervaert; C O Savage; C G Kallenberg
Journal:  Curr Opin Rheumatol       Date:  2000-01       Impact factor: 5.006

3.  Disappearance of immunoglobulin and complement from the Arthus reaction and its relevance to studies of vasculitis in man.

Authors:  J J Cream; A D Bryceson; G Ryder
Journal:  Br J Dermatol       Date:  1971-02       Impact factor: 9.302

4.  Immunopathological studies of polyarteritis nodosa and Wegener's granulomatosis: a report of 43 patients with 51 renal biopsies.

Authors:  P Ronco; P Verroust; F Mignon; O Kourilsky; P Vanhille; A Meyrier; J P Mery; L Morel-Maroger
Journal:  Q J Med       Date:  1983

5.  In vivo antinuclear antibodies (ANA) in biopsies of normal skin: diagnostic significance and relation to serum ANA.

Authors:  C G Kallenberg; M C de Jong; T M Walstra; S Kardaun; T H The
Journal:  J Rheumatol       Date:  1983-10       Impact factor: 4.666

6.  Wegener's granulomatosis: cutaneous and oral mucosal disease.

Authors:  S F Patten; K J Tomecki
Journal:  J Am Acad Dermatol       Date:  1993-05       Impact factor: 11.527

7.  Wegener's granulomatosis in childhood: cutaneous manifestations as the presenting signs.

Authors:  J Y Chyu; W J Hagstrom; K Soltani; B Faibisoff; D H Whitney
Journal:  J Am Acad Dermatol       Date:  1984-02       Impact factor: 11.527

8.  Occurrence of vascular IgA deposits in clinically normal skin of patients with renal disease.

Authors:  E H Faille-Kuyper; L Kater; R H Kuijten; C J Kooiker; S S Wagenaar; P van der Zouwen; E J Mees
Journal:  Kidney Int       Date:  1976-05       Impact factor: 10.612

9.  Glomerular injury induced by cationic 70-kD staphylococcal protein; specific immune response is not involved in early phase in rats.

Authors:  Y Fujigaki; Y Yousif; T Morioka; S Batsford; A Vogt; A Hishida; M Miyasaka
Journal:  J Pathol       Date:  1998-04       Impact factor: 7.996

10.  The role of polymorphonuclear leukocytes in the initiation and cessation of the Arthus vasculitis.

Authors:  C G COCHRANE; W O WEIGLE; F J DIXON
Journal:  J Exp Med       Date:  1959-09-01       Impact factor: 14.307

View more
  12 in total

Review 1.  Antineutrophil cytoplasmic autoantibodies: how are they detected and what is their use for diagnosis, classification and follow-up?

Authors:  Jan Willem Cohen Tervaert; Jan Damoiseaux
Journal:  Clin Rev Allergy Immunol       Date:  2012-12       Impact factor: 8.667

Review 2.  Pathogenesis of ANCA-associated vasculitis.

Authors:  Rodrigo Cartin-Ceba; Tobias Peikert; Ulrich Specks
Journal:  Curr Rheumatol Rep       Date:  2012-12       Impact factor: 4.592

3.  [Vasculitis: New nomenclature of the Chapel Hill consensus conference 2012].

Authors:  K Holl-Ulrich
Journal:  Z Rheumatol       Date:  2014-11       Impact factor: 1.372

4.  Clinicopathologic correlation of 282 leukocytoclastic vasculitis cases in a tertiary hospital: a focus on direct immunofluorescence findings at the blood vessel wall.

Authors:  Caroline Maris Takatu; Antonio Pedro Ribeiro Heringer; Valéria Aoki; Neusa Yuriko Sakai Valente; Paula Cristina de Faria Sanchez; Jozélio Freire de Carvalho; Paulo Ricardo Criado
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

Review 5.  Pathogenesis of ANCA-associated vasculitis.

Authors:  Julia Flint; Matthew D Morgan; Caroline O S Savage
Journal:  Rheum Dis Clin North Am       Date:  2010-06-23       Impact factor: 2.670

Review 6.  [Vasculitis. New nomenclature of the Chapel Hill consensus conference 2012].

Authors:  K Holl-Ulrich
Journal:  Pathologe       Date:  2013-11       Impact factor: 1.011

Review 7.  Mechanisms of vascular damage in ANCA vasculitis.

Authors:  David Massicotte-Azarniouch; Carolina A Herrera; J Charles Jennette; Ronald J Falk; Meghan E Free
Journal:  Semin Immunopathol       Date:  2022-03-07       Impact factor: 11.759

8.  Immune deposits in cutaneous lesions of Wegener's granulomatosis: predictor of an active disease.

Authors:  Seema Chhabra; Ranjana W Minz; Lekha Rani; Nidhi Sharma; Vinay Sakhuja; Aman Sharma
Journal:  Indian J Dermatol       Date:  2011-11       Impact factor: 1.494

9.  Fulminant primary manifestations of Wegener's granulomatosis might not be pauci-immune.

Authors:  Ulf Schönermarck; Maja Grahovac; Miklós Sárdy; Michael Dolch; Andreas Wollenberg
Journal:  NDT Plus       Date:  2010-08-05

Review 10.  Linking classification and therapeutic management of vasculitides.

Authors:  Corisande Baldwin; Simon Carette; Christian Pagnoux
Journal:  Arthritis Res Ther       Date:  2015-06-02       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.